Posted on September 21, 20219/21/21
Novel Antibiotic Opportunity in China
Posted on September 20, 20219/20/21
How Do You Know Your Portfolio Process Is Adding Value?
Posted on September 14, 20219/14/21
Simplifying EU Distribution to Maximize Cost Efficiency and Speed to Market for Patients and Manufacturers
Posted on September 7, 20219/7/21
Adapting Patient Access Programs to Asia
Posted on September 6, 20219/6/21
Optimizing Your Digital Marketing Spend and Field Deployment to Impact Script Adoption
Posted on July 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on June 23, 20216/23/21
Considering a Virtual Advisory Board as a Viable, Cost-Effective Option for PMR Planning
Posted on June 23, 20216/23/21
The Rise of Digital Therapeutics Opportunities in China
Posted on June 19, 20216/19/21
Transform Your Medical Information Contact Center Into a Strategic Asset for Customer Engagement
Posted on May 26, 20215/26/21